פייקומפה 12 מג טבליות מצופות

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

PERAMPANEL AS ANHYDROUS

Disponível em:

EISAI ISRAEL LTD., ISRAEL

Código ATC:

N03AX22

Forma farmacêutica:

טבליות מצופות פילם

Composição:

PERAMPANEL AS ANHYDROUS 12 MG

Via de administração:

פומי

Tipo de prescrição:

מרשם נדרש

Fabricado por:

EISAI MANUFACTURING LIMITED, UK

Grupo terapêutico:

PERAMPANEL

Área terapêutica:

PERAMPANEL

Indicações terapêuticas:

Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

Resumo do produto:

א. התרופה תינתן לטיפול באפילפסיה, לאחר מיצוי הטיפול בשתי תרופות אנטי אפילפטיות קודמות לפחות. ב. מתן התרופה ייעשה על פי מרשם של רופא מומחה בנוירולוגיה.

Data de autorização:

2018-07-31

Folheto informativo - Bula

Page 1 of 8 " )
(
–
1986
2 ,
"
4 ,
"
6
,
"
8 ,
"
10 ,
"
12 "
:
:
Perampanel (as anhydrous)
2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg
2
"
78.5
"
4
"
157.0
"
6
"
151.0
"
8
"
149.0
"
10
"
147.0
"
12
"
145.0
"
:
6
,
."
"
.
.
.
,
.
.
.
.
1 .
?
,
,
:
−
(
partial-
onset seizures
)
(
secondary
generalized seizures
)
4
.
−
(Primary generalized Tonic-clonic seizures)
(
idiopathic generalized epilepsy
)
12
:
AMPA
.
-
.
–
.
.
Page 2 of 8
2 .
:
:
•
/
,
.
•
,
)
(
(
6
-
"
"
.)
:
: ,
•
.
•
.
•
.
•
.
•
.
,
.
•
,
.
.
,
.
,
,
/
.
/
,
.
-
.
,
!
(
350
)
״
/
(DRESS)
-
'
(
Stevens - Johnson Syndrome (SJS)
)
.
-
–
DRESS
:
,
,
-
,
,
(eosinophilia)
.
-
-
'
(
SJS
)
–
.
,
,
,
,
(
.)
,
/
.
.
(
)
,
.
:
•
4
,
(partial seizures)
.
•
12
,
(
generalized tonic clonic seizures
)
.
Page 3 of 8
-
partial seizures
,
4
-
generalized tonic clonic seizures
12
.
/
: ,
.
.
.
:
•
-
:
,
(
felbamate
,)
(
carbamazepine
)
,
(
oxcarbazepine
)
(
phenytoin
)
.
.
•
(
midazolam
)
(
,
(
,)
,
)
.
(
midazolam
)
.
•
(
rifampicin
)
,
;
•
(
st. john's wort
,)
;
(
ketoconazole
)
–
.
.
•
–
,
(
,
)
,
(
levonorgestrel
)
.
,
.)
)
(
(
.
:
.
:
.
.
.
,
.
, ,
:
,
,
.
,
.
.
(
-
)
.
,
.
.
.
Page 4 of 8
.
.
:
.
.
.
.
.
.)
(
,
.
3 .
?
.
.
.
•
:
(
12 ) )
(
)
(
:
2
.
"
•
2
"
4
–
12
"
,
.
•
,
-
8
"
,
.
•
.
.
4
11
.
.
30 "
20
-
30 "
-
20 "
2
"
/
1
"
/
1
"
/
4-8
"
/
4-6
"
/
2-4
"
/
12
"
/
8
"
/
6
"
/
(
4
11 )
30
"
:
2
"
.
Page 5 of 8
•
-
2
"
4
"
-
8
"
.
,
12
"
.
•
,
-
4
"
,
.
•
.
.
(
4
11 )
20
"
-
30
"
:
1
"
.
•
-
1
"
4
"
-
6
"
.
,
8
"
.
•
,
-
4
"
,
.
•
.
.
(
4
11 )
-
20
"
:
1
"
.
•
-
1
"
2
"
-
4
"
.
,
6
"
.
•
,
-
4
"
,
.
•
.
.
•
.
.
: / /
•
,
.
•
.
,
,
.
,
.
,
.
.
.
"
-
7
.
,
-
7
,
.
,
.
,
.
.
Page 6 of 8
• ! .
.
.
,
4 .
: , . .
.
-
.
! ,
(
:)
•
•
(
-
1
–
10
100
:)
•
,
•
,
,
,
•
(
,
,
)
•
•
•
)
(
•
•
•
)
(
•
(
10
-
1
1,000
:)
•
,
,
•
.)
,
(
•
/
)
(
.
(
:)
•
,
DRESS
:
,
,
,
(
eosinophilia
,)
.
•
-
'
,
SJS
:
:
,
,
,
,
,
.
.
•
.
2
."
" , ,
.
Page 7 of 8
"
“
"
(www.health.gov.